Futura Medical (LON:FUM) Announces Quarterly Earnings Results

Futura Medical (LON:FUM) announced its quarterly earnings data on Tuesday. The company reported GBX (0.20) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%.

Futura Medical Trading Down 11.1%

Shares of FUM stock traded down GBX 0.04 during mid-day trading on Tuesday, reaching GBX 0.34. The stock had a trading volume of 18,383,107 shares, compared to its average volume of 9,129,860. The company has a market cap of £1.96 million, a P/E ratio of -0.12 and a beta of 0.02. Futura Medical has a 12-month low of GBX 0.24 and a 12-month high of GBX 10.45. The business has a 50-day simple moving average of GBX 0.43 and a 200 day simple moving average of GBX 0.80.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.